0 items USD 0.00Search
- Did you mean
- veinsight akt1 inhibitors pipeline insights 2018
Your search for "delveinsight akt3 inhibitors pipeline insights 2016" gave back 49633 results.
Protein kinase B inhibitors are molecules used to deactivate protein kinase B enzymes. In the context of China-US trade war and COVID-19 epidemic, it...
Catalog:
9Dimen Research
April 2021
Price: USD 3,200.00
The global AKT Inhibitor market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of %...
Catalog:
GIR
December 2023
Price: USD 3,480.00
The global AKT Inhibitor market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-...
Catalog:
GIR
December 2023
Price: USD 4,480.00
The global AKT Inhibitor market size was valued at US$ million in 2022. With growing demand in downstream market, the AKT Inhibitor is forecast to a...
Catalog:
LPI
December 2023
Price: USD 3,660.00
The “PI3K & AKT & mTor Pathway Inhibitors for Breast Cancer Industry Forecast” looks at past sales and reviews total world PI3K & AKT...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Market Analysis and Insights: Global PI3K & AKT & mTor Pathway Inhibitors for Breast Cancer Market The global PI3K & AKT & mTor...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Highlights The global PI3K & AKT & mTor Pathway Inhibitors for Breast Cancer market was valued at US$ million in 2022 and is anticipated to...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Competitor Analysis: PD-1 and PD-L1 Immune Checkpoint Inhibitors 2016 This Competitive Intelligence report about PD-1 and PD-L1 Immune Checkpoint...
Catalog:
La Merie Publishing
October 2016
Price: USD 450.00
Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology This product consists of four reports in pdf format describing...
Catalog:
La Merie Publishing
December 2016
Price: USD 1,386.00
Competitor Analysis: IDO & TDO Inhibitors for Modulation of the Tumor Microenvironment This industry report describes the competitive R&D...
Catalog:
La Merie Publishing
December 2016
Price: USD 220.00
Competitor Analysis: TGF-β Inhibitors for Modulation of the Tumor Microenvironment This industry report describes the competitive R&D landscape...
Catalog:
La Merie Publishing
December 2016
Price: USD 220.00
Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-β/R, CXCR4, CSF-1R, CD47-SIRPα, Adenosine, STING & Others This Competitive...
Catalog:
La Merie Publishing
December 2016
Price: USD 770.00
Competitor Analysis: Inhibitors of Negative Immune Checkpoints CTLA-4, LAG-3, TIM-3 & Others This Competitive Intelligence report about...
Catalog:
La Merie Publishing
November 2016
Price: USD 550.00
Competitor Analysis: CXCR4 Antagonists for Modulation of the Tumor Microenvironm ent This industry report describes the competitive R&D landscape...
Catalog:
La Merie Publishing
December 2016
Price: USD 220.00
Competitor Analysis: CSF-1R Antagonists for Modulation of the Tumor Microenvironment This industry report describes the competitive R&D landscape...
Catalog:
La Merie Publishing
December 2016
Price: USD 220.00
